The Ontario Superior Court in Canada declared the rules that govern medical marijuana access and the prohibitions laid out in sections 4 and 7 of the Controlled Drugs and Substances Act “constitutionally invalid and of no force and effect,” effectively paving the way for legalization. If the government does not respond within 90 days with a successful delay or re-regulation of marijuana, the drug will be legal to possess and produce in Ontario, where the decision is binding.
Research into medicinal marijuana is undergoing a surge of interest, with more evidence emerging not only of its ability to ease human suffering, but also of its apparent safety. Some say cannabis may be less toxic to humans than over-the-counter pain relievers. Scientifically controlled experiments have concluded that smoked cannabis can provide moderate relief from chronic, severe non-cancer pain — including HIV-related nerve pain and post-traumatic neuropathy, a condition that can follow an injury or medical procedure. Both are notoriously resistant to conventional treatments. (See also: Ten Years of Medical Marijuana in Canada)
Data obtained by the Ottawa Citizen through the Access to Information Act put a face to the typical medical marijuana patient for the first time, 10 years after the federal government — under pressure from a series of legal rulings — was forced to start allowing seriously ill Canadians to apply to use the drug. As Health Canada moves to overhaul the rules governing medical marijuana, its own numbers show sharp disparities in the accessibility and use of the drug across the country as patients scramble to find doctors willing to prescribe. (See also: Ten Years of Medical Marijuana in Canada)